NCT02754362 2020-01-13A Toll-like Receptor Agonist as an Adjuvant to Tumor Associated Antigens (TAA) Mixed With Montanide ISA-51 VG With Bevacizumab for Patients With Recurrent GlioblastomaNYU Langone HealthPhase 2 Withdrawn